Cargando…
Inhibition of Hepatitis C Virus 3a genotype entry through Glanthus Nivalis Agglutinin
BACKGROUND: Hepatitis C Virus (HCV) has two envelop proteins E1 and E2 which is highly glycosylated and play an important role in cell entry. Inhibition of virus at entry step is an important target to find antiviral drugs against HCV. Glanthus Nivalis Agglutinin (GNA) is a mannose binding lectin wh...
Autores principales: | Ashfaq, Usman A, Masoud, Muhammad S, Khaliq, Saba, Nawaz, Zafar, Riazuddin, Sheikh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117843/ https://www.ncbi.nlm.nih.gov/pubmed/21599979 http://dx.doi.org/10.1186/1743-422X-8-248 |
Ejemplares similares
-
Glycyrrhizin as antiviral agent against Hepatitis C Virus
por: Ashfaq, Usman A, et al.
Publicado: (2011) -
Lysosomotropic agents as HCV entry inhibitors
por: Ashfaq, Usman A, et al.
Publicado: (2011) -
In-vitro model systems to study Hepatitis C Virus
por: Ashfaq, Usman Ali, et al.
Publicado: (2011) -
Synergistic antiviral effect of Galanthus nivalis agglutinin and nelfinavir against feline coronavirus
por: Hsieh, Li-En, et al.
Publicado: (2010) -
Inhibition of HCV 3a core gene through Silymarin and its fractions
por: Ashfaq, Usman Ali, et al.
Publicado: (2011)